Regenxbio (RGNX) FCF Margin (2014 - 2025)
Regenxbio's (RGNX) quarterly FCF Margin came in at 200.52% in Q4 2025, down 5301.0% year-on-year from 3.86% in Q4 2024, and down 2.18% quarter-over-quarter from 196.24% in Q3 2025.
Regenxbio (RGNX) FCF Margin (2014 - 2025) Analysis & Trends
Regenxbio's FCF Margin history runs 12 years deep, the most recent figure standing at 200.52% for Q4 2025.
- On a quarterly basis, FCF Margin fell 5301.0% year-over-year to 200.52% in Q4 2025; TTM through Dec 2025 was 76.46%, a 13216.0% increase from a year earlier, with the FY2025 full-year figure at 80.87%, up 12592.0% from the prior year.
- FCF Margin declined to 200.52% in Q4 2025 per RGNX's latest filing, from 196.24% in the prior quarter.
- Across five years, FCF Margin topped out at 102.54% in Q4 2021 and bottomed at 447.99% in Q1 2023.
- The 5-year median for FCF Margin is 198.37% (2022), against an average of 194.59%.
- Across the five-year window, FCF Margin sank 32879 bps in 2021 and jumped 40250 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 102.54% in 2021, then tumbled by 216 bps to 119.38% in 2022, then decreased by 14 bps to 136.57% in 2023, then declined by 8 bps to 147.51% in 2024, then tumbled by 36 bps to 200.52% in 2025.
- Per Business Quant, the three latest RGNX FCF Margin figures stand at 200.52% (Q4 2025), 196.24% (Q3 2025), and 216.29% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | -200.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -200.52% |
| Sep 30, 2025 | -196.24% |
| Jun 30, 2025 | -216.29% |
| Mar 31, 2025 | 37.46% |
| Dec 31, 2024 | -147.51% |
| Sep 30, 2024 | -173.31% |
| Jun 30, 2024 | -197.19% |
| Mar 31, 2024 | -365.04% |
| Dec 31, 2023 | -136.57% |
| Sep 30, 2023 | -210.30% |
| Jun 30, 2023 | -199.93% |
| Mar 31, 2023 | -447.99% |
| Dec 31, 2022 | -119.38% |
| Sep 30, 2022 | -199.54% |
| Jun 30, 2022 | -153.94% |
| Mar 31, 2022 | -301.01% |
| Dec 31, 2021 | 102.54% |
| Sep 30, 2021 | -356.32% |
| Jun 30, 2021 | -157.46% |
| Mar 31, 2021 | -253.31% |